Compile Data Set for Download or QSAR
maximum 50k data
Found 75 Enz. Inhib. hit(s) with all data for entry = 870
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294974(US10112911, Example 1.39)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294975(US10112911, Example 1.40)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294976(US10112911, Example 1.41)
Affinity DataEC50:  1.22E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294977(US10112911, Example 1.42)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294978(US10112911, Example 1.43)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294979(US10112911, Example 1.44)
Affinity DataEC50:  120nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294980(US10112911, Example 1.45)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294981(US10112911, Example 1.46)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294982(US10112911, Example 1.47)
Affinity DataEC50: >1.38E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294983(US10112911, Example 1.48)
Affinity DataEC50:  1.34E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294984(US10112911, Example 1.49)
Affinity DataEC50: >3.20E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294985(US10112911, Example 1.50)
Affinity DataEC50: >3.20E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294986(US10112911, Example 1.51)
Affinity DataEC50:  690nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294987(US10112911, Example 1.52)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294988(US10112911, Example 1.53)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294989(US10112911, Example 1.54)
Affinity DataEC50:  260nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294990(US10112911, Example 1.56)
Affinity DataEC50:  1.60E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294991(US10112911, Example 1.57)
Affinity DataEC50:  290nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294992(US10112911, Example 1.58)
Affinity DataEC50: >3.20E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294993(US10112911, Example 1.59)
Affinity DataEC50: >3.20E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294994(US10112911, Example 1.60)
Affinity DataEC50:  1.05E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294995(US10112911, Example 1.61)
Affinity DataEC50: >6.60E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294996(US10112911, Example 1.62)
Affinity DataEC50: >3.20E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294997(US10112911, Example 1.63)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294998(US10112911, Example 1.64)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294999(US10112911, Example 1.65)
Affinity DataEC50:  5.90E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295000(US10112911, Example 1.66)
Affinity DataEC50:  1.50E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295001(US10112911, Example 1.67)
Affinity DataEC50:  360nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295002(US10112911, Example 1.68)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295003(US10112911, Example 1.69)
Affinity DataEC50:  2.99E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295004(US10112911, Example 1.70)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295005(N′-cyano-2-isopropyl-N-(4-methylpyridin-3-yl...)
Affinity DataEC50: >5.37E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295006(N′-cyano-2-isopropyl-N-(2-methylpyridin-3-yl...)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295007(N′-cyano-N-(2-methylphenyl)-4-(quinoxalin-2-...)
Affinity DataEC50: >6.17E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295008(N′-cyano-2-isopropyl-N-methyl-N-(2-methylphe...)
Affinity DataEC50:  3.40E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295009(2-cyano-1-(2-methylphenyl)-3-[3-methyl-1-(quinoxal...)
Affinity DataEC50: >1.00E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM295010(N′-cyano-7-isopropyl-N-(2-methylphenyl)-4-(q...)
Affinity DataEC50: >3.20E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294857(US10112911, Example 1.1)
Affinity DataEC50:  890nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294858(US10112911, Example 1.2)
Affinity DataEC50:  1.13E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294859(US10112911, Example 1.3)
Affinity DataEC50:  250nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294878(US10112911, Example 1.4)
Affinity DataEC50:  1.14E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294913(US10112911, Example 1.5)
Affinity DataEC50:  810nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294914(US10112911, Example 1.6)
Affinity DataEC50:  1.59E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294942(US10112911, Example 1.7)
Affinity DataEC50:  830nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294943(US10112911, Example 1.8)
Affinity DataEC50:  450nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294944(US10112911, Example 1.9)
Affinity DataEC50:  4.09E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294945(US10112911, Example 1.10)
Affinity DataEC50:  430nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294946(US10112911, Example 1.11)
Affinity DataEC50:  1.41E+3nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294947(US10112911, Example 1.12)
Affinity DataEC50: >3.20E+4nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein M2-1(Human respiratory syncytial virus A (strain A2))
Abbvie

US Patent
LigandPNGBDBM294948(US10112911, Example 1.13)
Affinity DataEC50:  200nMAssay Description:A cytopathetic effect (CPE) protection assay was performed to determine the ability of a compound to protect the cells from viral infection and thus ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: